Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05180747 · ClinicalTrials.gov registry record · NA

BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial

A NA study of Parkinson Disease, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05180747 is a NA study of Parkinson Disease that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05180747, a NA study of Parkinson Disease, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Many patients with Parkinson's Disease (PD) will encounter difficulties with balance, posture, and gait for which physical therapy (PT) has been shown to be beneficial. The purpose of this study is to randomize patients between standard "burst" PT versus "spaced" PT to inform on the optimal frequency of PT for PD patients. Burst PT in this study was defined as 2 PT visits per week for 6 weeks (12 sessions) and spaced PT, as 1 PT visit every other week for 6 months (12 sessions).

Conditions Studied

Interventions

  • OTHER Frequency of physical therapy sessions

Study Locations (1)

Florida

  • Norman Fixel Institute for Neurological Diseases - Gainesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-08-03
Est. Completion 2021-10-01
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05180747

The ClinicalTrials.gov registry entry for NCT05180747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Frequency of physical therapy sessions is the first listed.

NCT05180747 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05180747 about?

NCT05180747 is a clinical study titled "BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial". Many patients with Parkinson's Disease (PD) will encounter difficulties with balance, posture, and gait for which physical therapy (PT) has been shown to be beneficial. The purpose of this study is to randomize patients between standard "burst" PT versus "spaced" PT to inform on the optimal frequenc...

What is the current status of trial NCT05180747?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-08-03. Estimated completion is 2021-10-01.

What conditions does trial NCT05180747 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05180747?

The interventions under investigation include: Frequency of physical therapy sessions (OTHER).

Who is sponsoring clinical trial NCT05180747?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05180747 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.